adjuvant chemotherapy


Also found in: Dictionary, Thesaurus, Medical, Wikipedia.
Related to adjuvant chemotherapy: Neoadjuvant chemotherapy

adjuvant chemotherapy

[¦a·jə·vənt ‚kē·mō′ther·ə·pē]
(medicine)
Chemotherapy that is used to destroy suspected undetectable residual tumor after surgery or radiation treatment has eradicated all detectable tumor; effective in the treatment of breast and colon cancer.
References in periodicals archive ?
To evaluate the necessity of adjuvant chemotherapy, predictive mathematical models were established to systematically evaluate the influence of each factor on the patients' OS and DFS [Table 2] and [Table 3].
Furthermore, diminished total dose and dose intensity of adjuvant chemotherapy both have been associated with lower breast cancer survival rates.
One retrospective report showed that time between surgery and initiation of adjuvant chemotherapy for more than 10 weeks showed no effect in survival outcome.
Ghert, "A systematic meta-analysis of randomized controlled trials of adjuvant chemotherapy for localized resectable soft-tissue sarcoma," Cancer, vol.
Neurocognitive performance in breast cancer survivors exposed to adjuvant chemotherapy and tamoxifen.
At present, new adjuvant chemotherapy has been applied to patients diagnosed with stage III NSCLC to obtain definite efficacy.
For example, black women have been shown to be less likely to receive adjuvant chemotherapy (Bhargava and Du 2009; Freedman et al.
Whether all patients with locally advanced rectal cancer should receive adjuvant chemotherapy is still controversial.
Eighteen patients received neoadjuvant chemotherapy and/or radiation, with four of these patients eventually receiving additional therapy after pneumonectomy; eight patients received adjuvant chemotherapy and/or radiation, and ten patients received surgery alone (Table 1).
Although EMP has a relatively good prognosis and responds well to local treatment, adjuvant chemotherapy should be a consideration for the management of the disease.
Although adjuvant chemotherapy (ACT) has increased survival rates and has become standard treatment for NSCLC, a proportion of patients do not derive any benefit from it.
Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer.